The Trans-Pacific Partnership has several issues about the United States in regards to the control with limiting /minimizing regulation, helping corporate interest on an international level, and inflicting fiercer standards of Intellectual Property (IP). Those arguments show its validity in various aspects of the agreement and there is no coincidence that the U.S. led and pushed for the proposals. However, while the United States proposes for the reformation of international laws it incorporates Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, and Vietnam as signatory nations that fall under U.S. global domination. Throughout the research I could not find much discussion about how the public health and Intellectual Property (IP) display traces of neoliberal influence. My objective of this paper is to discuss how the U.S. uses the Trans-Pacific Partnership agreement as a strategic element to increase their power in different areas by connecting three of their TPP proposals.
To further understand and reach my objective, I have formatted my paper into three main sections. In the first section, I present the topic of pharmaceutical companies. In the first part of the section are the four provisions that would involve patents and how it would begin the creation of monopolistic companies. I then mention on how the pharmaceutical companies would then have the access to increase drug prices and the consequences it has on consumers. In my second I focus on HIV/AIDS drugs and provide the problem and how it has affected developing countries. In my last section I focus on food safety regulations. I explain the three ways that the international markets have been used as dominating consumer acceptance. I...
... middle of paper ...
...Web. 15 May 2014.
Friel, Sharon, et al. "A New Generation Of Trade Policy: Potential Risks To Diet-Related Health From The Trans Pacific Partnership Agreement." Globalization & Health 9.1 (2013): 1-15. Academic Search Complete. Web. 15 May 2014.
Lewis, Meredith Kolsky. "The Trans-Pacific Partnership: New Paradigm Or Wolf In Sheep's Clothing?" Boston College International & Comparative Law Review 34.1 (2011): 27-52. Academic Search Complete. Web. 15 May 2014.
Löfgren, Hans. "The Trans-Pacific Partnership Agreement: a threat to affordable medicines and public health." Southern Med Review Dec. 2011: 2. Academic Search Complete. Web. 15 May 2014.
Lopert, Ruth, and Deborah Gleeson. "The High Price Of 'Free' Trade: U.S. Trade Agreements And Access To Medicines." Journal Of Law, Medicine & Ethics 41.1 (2013): 199-223. Consumer Health Complete - EBSCOhost. Web. 15 May 2014.
In “Bad Food” – What’s the Best Food? Tax it, and Subsidize Vegetables”, Mark Bittman suggests that the people of America should stop eating unhealthy foods so often. In the article, Bittman tells his audience that people with “heart disease, diabetes and cancer are all in large part caused by the standard American Diet” (page 35). He also states that eating healthy can result in a better health care system, saving millions of lives. The big issue is Americans eating unhealthy every day, but proposing a plan to help stop it from happening.
I am used to living a very busy life style, so I never paid close attention to where my food was originating from. Usually when I look at my food it is more to find out its nutritional value rather than its origins. After reading Kelsey Timmerman’s “Where Am I Eating?”, it has opened my eyes to some of the horrors of the food industry. Regardless of what I have learned, changing my eating habits would be very challenging, and I do not believe it is entirely necessary. Yes, there are many negatives in the global food economy, but it is not totally corrupt as Timmerman suggests. I believe it would be very difficult to change because of the many misleading food labels, the United States has become unfamiliar with how to produce for the entirety
As the Western world experiences increasing occurrences of certain diseases, society is focusing not only on finding the source of this phenomena but also on finding a solution to the problem. In his essay “Escape from the Western Diet”, Michael Pollan places the blame on the Western diet, arguing that people need only to change their eating habits in order to prevent many chronic diseases. While the author makes a compelling argument, his usage of logical fallacies, his questionable credibility, and his apparent bias weaken his point; nonetheless, I agree with his overall surmise that the western diet should be improved.
Nestle, Marion. Food Politics: How the Food Industry Influences Nutrition and Health. Berkeley: University of California Press, 2002.
Federal Trade Commission, 1979. Braithwalte, John. The. Corporate Crime in the Pharmaceutical Industry? Boston, MS: Routledge & Kegan Paul, 1984.
... (2013) IMS health study points to a declining cost curve for U.S. medicines in 2012 Retrieved from http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vgnextoid=8659cf4add48e310VgnVCM10000076192ca2RCRD&vgnextchannel=437879d7f269e210VgnVCM10000071812ca2RCRD&vgnextfmt=default
A monopoly exists when a specific individual or an enterprise has sufficient control over a particular product or service to determine significantly the terms on which other individuals shall have access to it. A monopoly sells a good for which there is no close substitute. The absence of substitutes makes the demand for the good relatively inelastic thereby enabling monopolies to extract positive profits. It is this monopolizing of drug and process patents that has consumer advocates up in arms. The granting of exclusive rights to pharmacuetical companies over clinical a...
Kinney, Eleanor D. "Realization of the International Human Right to Health in an Economically Integrated North America." Journal of Law, Medicine & Ethics 37.4 (2009): 807-818. Academic Search Premier. EBSCO. Web. 15 Mar. 2011.
Pang, T. (2004, October ). Globalization and Risks to health . Retrieved 4 22, 2014, from National Library of Medicine: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299207/
Government factors into the equation of the argument. Critics of the drug industry say that there is not enough regulation, while supporters of the pharmaceutical companies argue that there is too much regulation and that that is one...
All markets may be affected by parts of the four criteria however, some markets are operationally reliant on on them, and these are the markets, Satz argues, are noxious markets, that need regulating. Satz focuses on “noxious markets” because they can restrain or undermine the development of desirable human qualities, shape preferences in undesirable ways or promote objectionable social relationships. Satz argues that the solution is not prohibition because the consequences of prohibition may be worse than the market itself. Satz instead states that markets need a greater r...
Although monopolies appear damaging at times, there are arguments that they are an advantage to society. Monopolies in the pharmaceutical industry drive companies to pursue research and development (R&D) efforts to gain new patents. According to a 1992 study, among the 24 US. Industry groups, pharmaceuticals dedicated 16.6% of their amounts to basic research, while all other industries averaged at 5.3% (Sherer 1307). This fact validates the incentive pharmaceutical companies have to get a patent and acquire more power. Pfizer encourages R&D because of the incentives and a want to obtain patents to receive more profit. Pfizer has to promote itself to be successful, creating a good brand image that consumers will trust. If the company can advertise successfully, more consumers will purc...
PROBLEM STATEMENT Teva Pharmaceuticals, the first multinational pharmaceutical company in Israel, has become a successful global giant in the industry of generic drugs. After experiencing a long period of success and growth in the generic drug industry against some big western pharmaceuticals, the company had acquired many well known pharmaceutical companies and had achieved its goal of $1 billion. theory seemed to be in trouble in building a new strategy and vision to compete with the rapidly growing generic industry. They confronted two big issues as key hurdles in their way.
Baylis, Smith and Patricia Owens. 2014. The 'Standard' of the 'Standard'. The globalization of world politics: An introduction to international relations. London.
Krain, Matthew (2005), “AP Comparative Government and Politics Briefing Paper: Globalization,” [http://apcentral.collegeboard.com/apc/public/repository/ap05_comp_govpol_glob_42253.pdf], accessed 15 May 2012.